FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

34051611000001101: Onexila XL 10mg tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103439601000001118 Onexila XL 10mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103439701000001111 Onexila XL 10mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Is a Oxycodone hydrochloride 10mg m/r tablet false Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Is a Onexila XL true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Is a Oxycodone 10mg modified-release tablets false Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) Is a Oxycodone 10mg modified-release tablets true Inferred relationship Existential restriction modifier
Onexila XL 10mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Onexila XL 10mg tablets (Aspire Pharma Ltd) 28 tablet 2 x 14 tablets Has AMP True Onexila XL 10mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start